<p>We analyzed monthly artemisinin combination therapy (ACT) and rapid diagnostic test (RDT) stock data from the District Health Information System (DHIS2) for public facilities at the general hospital level and below during 2017-2022. A facility was considered stocked out in a month if it reported ≥1 day of stockout of a commodity during that month. We calculated the proportion of facilities stocked out of ACT and RDTs per month and evaluated ACT stockouts by health facility type. We used the seasonal Mann-Kendall test and Sen’s slope estimator to evaluate trends. Districts were considered stocked out for a commodity in a year if the average monthly health facility stockout proportions were &gt;10% in that year.</p>